Long-acting inhaler combo best for curbing COPD flare-ups

Long-acting beta2-agonists plus long acting muscarinic antagonist most effective, finds Cochrane Review Related items fromOnMedica Antibiotics should be restricted for COPD, says NICE Good evidence for sublingual immunotherapy Adjuvanted trivalent flu vaccine best option for over-65s Inhaled corticosteroids linked to higher infection risk Antibiotic scrip rates lower in CAM-trained practices
Source: OnMedica Latest News - Category: UK Health Source Type: news